Living with diabetes has been made easier with insulin pumps and medications. However, the risk of developing complications remains high, and a diagnosis of diabetic retinopathy, the most common diabetic complication can be scary and confusing. Our laboratory is interested in the role of circadian rhythms in the progression of diabetic retinopathy, in chronotiming drug delivery and biomarker sampling and in designing non invasive lifestyle interventions to delay the onset of diabetic retinopathy.                                          

We are focused in studying physiological and systemic parameters affecting innate immunity and retinal health. We use type 1 and type 2 diabetic models and multi-omics approaches to identify metablic and microbial derived signatures that affect innate immune cell function and vascular health.